Want to see GB:SPI full AI Analyst Report?
SPI Stock Chart & Stats
224.00 p
9.25 p(4.13%)
At close: 4:00 PM EDT
224.00 p
9.25 p(4.13%)
Day’s Range― - ―
52-Week Range140.80 p - 256.50 p
Previous CloseN/A
Volume2.17M
Average Volume (3M)1.66M
Market Cap
£945.57M
Enterprise Value1.96K
Total Cash (Recent Filing)£34.70M
Total Debt (Recent Filing)£1.32B
Price to Earnings (P/E)57.3
Beta0.63
Next Earnings
Sep 09, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield0.64%
Share Statistics
EPS (TTM)0.04
Shares Outstanding402,759,600
10 Day Avg. Volume559,423
30 Day Avg. Volume1,661,785
Financial Highlights & Ratios
PEG Ratio-1.17
Price to Book (P/B)0.90
Price to Sales (P/S)0.42
P/FCF Ratio4.68
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)0.1
Revenue Forecast (FY)£1.65B
Bulls Say, Bears Say
Bulls Say
Sustained Revenue ExpansionThe substantial multi-year revenue increase indicates durable demand for Spire’s private healthcare, diagnostics and publicly funded services. Continued volume growth gives the group a broader base over which to spread hospital and clinical operating costs.
Consistent Positive Cash GenerationPositive operating and free cash flow provide internal funding for hospital investment, debt service and ongoing operations. The improvement through 2025 supports financial flexibility and reduces reliance on external capital to maintain the care network.
Stable Operating ProfitabilityStable operating and EBITDA margins suggest that Spire has retained reasonable control of core delivery costs despite operating complexity. Sustained profitability at the operating level supports the resilience of its hospital and clinic model.
Bears Say
Elevated LeverageHigh leverage leaves less balance-sheet protection if patient volumes, reimbursement or margins weaken. It can also increase sensitivity to financing costs and restrict capital allocation, making expansion and investment more dependent on cash-flow stability.
Weak Net-Income ConversionVery thin net margins leave limited room to absorb higher labour, operating, interest or tax costs. The decline in net income despite steady operating margins indicates that earnings conversion remains structurally weaker than the underlying revenue and EBITDA performance.
Limited Cash-Flow HeadroomAlthough cash generation is positive, moderate obligation coverage indicates limited resilience if operating cash flow deteriorates. Free cash flow below reported earnings also suggests that accounting profits do not consistently translate into cash available for debt reduction or reinvestment.
Spire Healthcare News
SPI FAQ
What was Spire Healthcare Group PLC’s price range in the past 12 months?
Spire Healthcare Group PLC lowest share price was 140.80 p and its highest was 256.50 p in the past 12 months.
What is Spire Healthcare Group PLC’s market cap?
Spire Healthcare Group PLC’s market cap is £945.57M.
When is Spire Healthcare Group PLC’s upcoming earnings report date?
Spire Healthcare Group PLC’s upcoming earnings report date is Sep 09, 2026 which is in 14 days.
How were Spire Healthcare Group PLC’s earnings last quarter?
Spire Healthcare Group PLC released its earnings results on Mar 05, 2026. The company reported 0.025 p earnings per share for the quarter, missing the consensus estimate of 0.05 p by -0.025 p.
Is Spire Healthcare Group PLC overvalued?
According to Wall Street analysts Spire Healthcare Group PLC’s price is currently Overvalued.
Does Spire Healthcare Group PLC pay dividends?
Spire Healthcare Group PLC pays a Annually dividend of 1.5 p which represents an annual dividend yield of 0.64%. See more information on Spire Healthcare Group PLC dividends here
What is Spire Healthcare Group PLC’s EPS estimate?
Spire Healthcare Group PLC’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Spire Healthcare Group PLC have?
Spire Healthcare Group PLC has 402,759,600 shares outstanding.
What happened to Spire Healthcare Group PLC’s price movement after its last earnings report?
Spire Healthcare Group PLC reported an EPS of 0.025 p in its last earnings report, missing expectations of 0.05 p. Following the earnings report the stock price went down -2.464%.
Which hedge fund is a major shareholder of Spire Healthcare Group PLC?
Currently, no hedge funds are holding shares in GB:SPI
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Spire Healthcare Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
6.10%
12-Months-Change
Fundamentals
Return on Equity
0.64%
Trailing 12-Months
Asset Growth
1.45%
Trailing 12-Months
Company Description
Spire Healthcare Group PLC
Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics in the United Kingdom. It operates in two segments: Hospitals Business and Primary Care. The company provides diagnostics, inpatient, day case, and outpatient care in areas, including orthopedics, gynaecology, cardiology, neurology, oncology, and general surgery; and primary care needs of outpatients, such as GP services, occupational health services, and mental and physical health services. It also offers various treatments in the areas of allergy and infectious diseases, blood tests, bones and joints, digestive and bowel treatments, breast screening and surgery, cancer investigations and treatments, cosmetic surgery, cyst removal, and dental surgery, as well as ear, nose, and throat treatments. In addition, the company provides eye surgery and treatments, family planning, gastroenterology, general medicine, haematology, hand surgery, hip and knee replacement treatment, and heart and kidney treatments. Further, it offers treatments in the areas of men's health, neurosurgery and neurology, paediatrics, pain management, rehabilitation, sports, physiotherapy, podiatry, respiratory medicine, and rheumatology; and scans and investigations, skin treatments, spinal neurosurgery, sports science, urology, vascular surgery, weight loss, and women's health. Additionally, the company provides treatments in the areas of breast enlargement, cataract removal surgery, gastric bypass surgery, and prostate surgery; and offers various tests and scans, which include cardiac CT, CT, MRI, ultrasound, and X-ray scans. Spire Healthcare Group plc was founded in 2007 and is headquartered in London, the United Kingdom.
Technical Analysis
Allergy Therapeutics
―
Circassia Pharmaceuticals
―
Craneware
―
PureTech Health
―
Optima Health PLC
―








